XML 31 R12.htm IDEA: XBRL DOCUMENT v3.22.4
STATEMENT OF CASH FLOWS - USD ($)
 3 Months Ended 8 Months Ended 9 Months Ended 11 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2021
Adjustments to reconcile net loss to net cash used in operating activities:              
(Gain) loss on change in fair value of SAFE and warrant liabilities       $ 427,000 $ 699,000   $ 563,000
Changes in operating assets and liabilities:              
Net cash used in operating activities       (71,336,000) (26,718,000)   (42,591,000)
Cash Flows From Investing Activities:              
Net cash used in investing activities       (6,530,000) (4,201,000)   (5,747,000)
Cash Flows From Financing Activities:              
Proceeds received from private placement             30,000,000
Net cash provided by financing activities       23,000 85,959,000   116,015,000
Cash, cash equivalents and restricted cash at beginning of period       128,732,000 60,909,000   60,909,000
Cash, cash equivalents and restricted cash at end of period $ 51,034,000 $ 115,700,000 $ 115,700,000 51,034,000 115,700,000 $ 128,732,000 128,732,000
AMCI ACQUISITION CORP. II              
Net Cash Provided by (Used in) Operating Activities [Abstract]              
Net loss     467,528 1,056,085   46,738  
Adjustments to reconcile net loss to net cash used in operating activities:              
General and administrative expenses paid by Sponsor in exchange for issuance of Class B common stock     1,000     1,000  
(Gain) loss on change in fair value of SAFE and warrant liabilities (1,426,720) (1,382,900) (1,382,900) (4,066,720)   (1,905,000)  
Offering costs allocated to derivative warrant liabilities   476,450 476,450     476,450  
Income from investments held in the trust account (733,042) (2,178) (2,178) (972,453)   (6,015)  
Changes in operating assets and liabilities:              
Prepaid expenses     49,173 244,534   155,454  
Accounts payable     3,000 1,602,381   85,534  
Due to related party           49,723  
Cash deposited in Trust Account     (150,000,000)        
Accrued expenses     138,034 1,127,030   199,733  
Capital base tax payable       133,578   198,129  
Franchise tax payable     134,845 (38,598)   188,237  
Net cash used in operating activities     (95,325) (345,097)   (510,017)  
Cash Flows From Investing Activities:              
Investment income released from Trust Account       9,000   (150,000,000)  
Net cash used in investing activities     (150,000,000) 9,000   (150,000,000)  
Cash Flows From Financing Activities:              
Proceeds from note payable to related party     1,000     1,000  
Proceeds received from initial public offering, gross     150,000,000     150,000,000  
Proceeds received from private placement     852,416     852,416  
Net cash provided by financing activities     150,853,416     150,853,416  
Net (decrease) increase in cash, cash equivalents and restricted cash     758,091 (336,097)   343,399  
Cash, cash equivalents and restricted cash at beginning of period     0 343,399   0  
Cash, cash equivalents and restricted cash at end of period $ 7,302 $ 758,091 758,091 $ 7,302 $ 758,091 343,399 $ 343,399
Supplemental disclosure of noncash activities:              
Offering costs included in notes payable     1,968,784        
Offering costs included in accrued expenses     30,000     30,000  
Offering costs paid by Sponsor in exchange for issuance of Class B common stock     24,000     24,000  
Offering costs included in notes payable           1,968,784  
Prepaid expenses paid by related party under note payable and advances     677,800     677,800  
Repayment of note payable and advances by Sponsor in exchange for issuance of private placement warrants     2,647,584     2,647,584  
Deferred underwriting commissions in connection with the initial public offering     5,250,000     5,250,000  
Value of Class B common stock transferred to Anchor Investors at initial public offering     $ 6,509,758     $ 6,509,758